The global DTP vaccines market size is expected to grow from $4.00 billion in 2021 to $4.45 billion in 2022 at a compound annual growth rate (CAGR) of 11.0%. The growth in the market is mainly due to the companies resuming their operations and adapting to the new normal while recovering from the COVID-19 impact, which had earlier led to restrictive containment measures involving social distancing, remote working, and the closure of commercial activities that resulted in operational challenges. The DTP vaccine market is expected to reach $5.79 billion in 2026 at a CAGR of 6.8%.
What is the Global DTP Vaccines Market?
The DTP vaccines market consists of sales of vaccines used for the treatment of diphtheria, tetanus, and pertussis (whooping cough) and related services by entities (organizations, sole traders and partnerships) that produce vaccines for diphtheria, tetanus, and pertussis (whooping cough). The different types of vaccines available for these diseases include DTaP (diphtheria, tetanus, and acellular pertussis) vaccine, DT (diphtheria and tetanus) vaccine, Tdap (combined tetanus, diphtheria and acellular pertussis) vaccine and TD (tetanus and diphtheria) vaccine. The market consists of revenue generated by the companies manufacturing DTP vaccines by the sales of these products.
Get a Sample of the global DTP vaccines market report:
https://www.thebusinessresearchcompany.com/sample.aspx?id=3453&&type=smp
What drives the Global DTP Vaccines Market?
Governments across the world are encouraging the R&D of DTP vaccines to disallow the spread of the diseases. Countries such as India have the Universal Immunisation Programme that aims to provide recommended vaccines against tuberculosis, polio and other diseases including diphtheria, tetanus and whooping cough for all Indian children. The country regularly conducts vaccination drives, which is expected to positively impact the growth of the market. These initiatives are expected to drive the growth of the market in the forecast period.
Get the full global DTP vaccines industry report here:
https://www.thebusinessresearchcompany.com/report/dtp-vaccine-global-market-report
Global DTP Vaccines Market Segments
The global DTP vaccines market is segmented:
By Product Type: DTaP, TD, Tdap
By Disease: Diphtheria, Pertussis, Tetanus.
By End-User: Hospitals, Clinics, Vaccination Centers
By Geography: The regions covered in the DTP vaccines market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.
DTP Vaccines Global Market Report 2022provides market size and growth forecasts for the global DTP vaccines market, global DTP vaccines market share, DTP vaccines market segments and geographies, DTP vaccines market competitive landscape including leading competitors’ revenues, profiles and market shares. The DTP vaccines market report identifies top countries and segments for opportunities and strategies based on market trends and leading competitors’ approaches.
Global DTP Vaccines Industry Playersinclude Merck & Co, Sanofi, GSK, Lanzhou Institute of Biological Products, Novartis AG, Pfizer Inc, Johnson & Johnson, Seqirus, AJ Vaccines, and Bionet-Asia. Based on industry trends and company analysis, the report explains a number of strategies for companies in the market.
